Search Results: PARP inhibitors

• Science & Technology
• Health & Medicine

Scientists exploit leaks in blood brain barrier to treat glioblastoma

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma. An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.

6 November 2017

• Health & Medicine

Targeted drug helps keep some advanced ovarian cancers at bay

Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening. Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.

8 September 2017

• For Researchers

Rucaparib: targeting DNA repair and a patient's perspective

Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib. Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib.

21 July 2017

• Charity News

Reviewing our year

Read about some of the progress we've made over the last financial year and about some of the big themes from the year. Read about some of the progress we've made over the last financial year and about some of the big themes from the year.

20 July 2017

• Science & Technology

More breast cancer patients than previously thought could benefit from existing targeted treatment

As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates. As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.

13 March 2017

• Health & Medicine

Ovarian cancer drug could target gene fault in brain tumours

A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest. A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest.

1 February 2017

• For Researchers

Future leaders and a lifetime in drug development: our research prizes

Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference. Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference.

16 November 2016

• Personal Stories

How your support is helping us beat breast cancer – Margaret’s story

The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more. The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more.

1 October 2016

• Science & Technology

CRT and SV Life Sciences form Artios Pharma to focus on DNA damage response

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma. Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.

21 September 2016

• Health & Medicine

Crashing cancer’s backup system – our progress so far

Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey? Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey?

12 September 2016